Amarin Corp Plcuk (AMRN) Short-term Investments (2020 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Short-term Investments of $176.8 million for Q1 2026, up 8.96% YoY from $162.3 million in Q1 2025, and up 5.28% sequentially from $167.9 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Short-term Investments (2020 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Short-term Investments across 7 years of filings, most recently posting $176.8 million for Q1 2026.

  • In Q1 2026, Short-term Investments rose 8.96% year-over-year to $176.8 million; the TTM figure through Mar 2026 stood at $176.8 million (up 8.96% YoY), while the FY2025 annual figure was $167.9 million, down 3.03% from the prior year.
  • Short-term Investments climbed to $176.8 million in Q1 2026, from $167.9 million in the prior quarter.
  • Over the last five years, Short-term Investments for AMRN reached as high as $176.8 million in Q1 2026 and fell as low as $49.8 million in Q3 2023.
  • The 5-year median for Short-term Investments is $121.4 million (2023), against an average of $122.1 million.
  • Annual changes were most pronounced in 2022 — Short-term Investments sank 75.34% — and 2024, when it soared 198.48%.
  • A 5-year view of Short-term Investments shows it stood at $91.7 million in 2022, then surged by 32.4% to $121.4 million in 2023, then surged by 42.65% to $173.2 million in 2024, then decreased by 3.03% to $167.9 million in 2025, then climbed by 5.28% to $176.8 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $176.8 million, $167.9 million, and $163.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 176.80 Mn
Dec 31, 2025 167.93 Mn
Sep 30, 2025 163.80 Mn
Jun 30, 2025 150.80 Mn
Mar 31, 2025 162.26 Mn
Dec 31, 2024 173.18 Mn
Sep 30, 2024 148.79 Mn
Jun 30, 2024 90.70 Mn
Mar 31, 2024 94.24 Mn
Dec 31, 2023 121.41 Mn
Sep 30, 2023 49.85 Mn
Jun 30, 2023 79.90 Mn
Mar 31, 2023 112.96 Mn
Dec 31, 2022 91.70 Mn
Sep 30, 2022 63.20 Mn
Jun 30, 2022 85.23 Mn
Mar 31, 2022 143.41 Mn
Dec 31, 2021 234.67 Mn
Sep 30, 2021 256.30 Mn
Jun 30, 2021 181.91 Mn